NCT06409039View on ClinicalTrials.gov

POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as a Prognostic Factor. Participants Are Women >= 18 Years Old, With the Pole Mutation

Enrolling by invitationOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 4, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

December 31, 2024

Conditions
Endometrial Neoplasms
Trial Locations (2)

31100

Aulss2 Marca Trevigiana Ospedale Ca Foncello, Treviso

Aulss2 Marca Trevigiana Ospedale Ca Foncello, Treviso

All Listed Sponsors
lead

Azienda Ulss 2 Marca Trevigiana

OTHER